{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T04:18:32Z","timestamp":1698466712205},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1364,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1998,4]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To compare the efficacy of cimetidine and tripotassium dicitrato bismuthate (TDB) in arthritic patients who had developed gastric (GU) or duodenal (DU) ulceration while taking non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Eighty\u2010six rheumatoid arthritis (RA) patients affected by endoscopically proven DU (<jats:italic>n\u2003<\/jats:italic>=\u200344) or GU (<jats:italic>n<\/jats:italic>\u2003=\u200342), and on chronic NSAID therapy which was not suspended during anti\u2010ulcer therapy, were randomized to cimetidine (400\u2003mg t.d.s.) or TDB (120\u2003mg q.d.s.). A repeat endoscopy was planned after 4\u2003weeks (and 8\u2003weeks, in case of failed healing). The patients who were unhealed after 8\u2003weeks of therapy were allocated to the alternative anti\u2010ulcer drug for a further 8\u2003weeks without interrupting the anti\u2010inflammatory therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>At week 4 of therapy, 14\/24 (58%) DU and 9\/20 (45%) GU patients treated with cimetidine were healed, compared with 12\/20 (60%) and 10\/22 (45%) TDB\u2010treated patients (N.S.). At week 8 of therapy, the DU healing rates were 15\/24 (63%) with cimetidine and 14\/20 (70%) for TDB. The corresponding GU healing rates were 12\/20 (60%) with cimetidine and 13\/22 (60%) for TDB (N.S.). At week 16, complete healing with cimetidine was observed in 67% of DU and 57% of GU patients unhealed with TDB; the corresponding figures in the patients crossed to TDB were 83% for DU and 63% for GU patients (N.S. vs. cimetidine).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>No statistically significant difference was found between the healing activities of cimetidine and TDB in rheumatoid arthritis patients with peptic ulcer who did not interrupt their NSAID treatment for arthritis. This trial showed that the continued consumption of NSAIDs appears to slow the ulcer healing process, especially in GU patients.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1998.00313.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:36:26Z","timestamp":1047353786000},"page":"343-347","source":"Crossref","is-referenced-by-count":1,"title":["Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment"],"prefix":"10.1111","volume":"12","author":[{"given":"G. Bianchi","family":"Porro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lazzaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ardizzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Manzionna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Montrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380103"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(05)70253-3"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91073-2"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6207.75"},{"key":"e_1_2_5_6_2","first-page":"1081","article-title":"Gastroduodenal complications of chronic NSAID therapy","volume":"83","author":"Graham DY","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-5-359"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.5.527"},{"key":"e_1_2_5_9_2","unstructured":"Bianchi PorroG&LazzaroniM.Colloidal bismuth subcitrate. In: Swabb EA Szabo S eds. Ulcer Disease. New York: Marcel Dekker 1991:287319."},{"key":"e_1_2_5_10_2","unstructured":"Bianchi PorroG.Modern medical treatment of peptic ulcer. In: Pathogenesis and the Treatment of Peptic Ulcer Disease. Proceedings of an International Symposium. Axon ATR ed. Excerpta Medica1985:1338."},{"key":"e_1_2_5_11_2","first-page":"291","article-title":"Anti\u2010ulcer activity of colloidal bismuth subcitrate in Shay rats","volume":"224","author":"Lavy U","year":"1976","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_5_12_2","first-page":"11","article-title":"Pharmacological properties of colloidal bismuth subcitrate (CBS, DeNol)","volume":"17","author":"Wierkis J","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/25.1.54"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.39.3.275"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2036.1988.tb00768.x","article-title":"Treatment of NSAID\u2010induced gastrointestinal lesions with cimetidine: an international multicentre collaborative study","volume":"25","author":"Bijlsma JWJ.","year":"1988","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.2.226"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.3.252"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1994.tb01277.x"},{"key":"e_1_2_5_19_2","unstructured":"RusselRJ.H. pylorieradication may reduce the risk of gastroduodenal lesions in chronic NSAIDs users.Ital J Gastroenterol Hepatol1997 in press."},{"key":"e_1_2_5_20_2","unstructured":"YeomansND LangstromG NaesdalJ WilsonI HawkeyCJ. Omeprazole vs. ranitidine for healing of NSAID\u2010associated ulcers and erosions in relation toH. pyloristatus. The astronaut study. Gastroenterology 1997; 112: A338."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00313.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00313.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1998.00313.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T01:54:18Z","timestamp":1698458058000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1998.00313.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1046\/j.1365-2036.1998.00313.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1998.00313.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}